Given the remarkably strong R&D pipeline in the area, a predicted half of all products on the global pharma market will be biologics by the year 2010. However, the demand for safe and effective biotherapeutics that can potentially treat diseases such as cancer, immunology infections and diabetes can only be met by establishing a competitive biomanufacturing sector. In order to claim a share of this lucrative market, biopharmaceutical developers need to overcome the complexities involved in the manufacturing operations, not only from the technical and operational perspectives, but also from a regulatory point of view.
|
|
The 4th annual Biomanufacturing Conference will bring experts from the industry and academy sector together to discuss the latest developments in biopharmaceutical processes and technology which can help to reduce costs, improve the efficiency of manufacturing plants and maximise downstream processing capacity. Through a series of presentations and interactive discussions, participants will gain new insight and share hands-on experiences in the latest trends and practices in the manufacturing of biopharmaceuticals.
|
